참고문헌
- Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manage. 2007;34: 94-104. https://doi.org/10.1016/j.jpainsymman.2006.10.015
- Addison Disease; adrenal gland disorders [Internet]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp.; c2007. [cited 2014 Jun 14]. Available from: http://www.merckmanuals.com/home/ hormonal_and_metabolic_disorders/adrenal_gland_disorders/addison _disease.html.
- Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins basic pathology. 8th ed. Philadelphia, PA:Saunders/Elsevier;2007. Table 20-7.
- Pediatric adrenal insufficiency (Addison Disease) [Internet]. New York, NY: Medscape; 2007. [cited 2014 Jun 20]. Available from: http://emedicine.medscape.com/article/919077.
- Pain control in palliative care [Internet]. Welwyn Garden City: EMIS Professional Pub.; 2012. [cited 2014 Jun 20]. Available from: http://www.patient.co.uk/doctor/pain-control-in-palliative-care.
- Scottish Intercollegiate Guidelines Network, NHS Quality Improvement Scotland. Control of pain in adults with cancer : a national clinical guideline. SIGN guideline, Series Number 106. Edinburgh:Scottish Intercollegiate Guidelines Network;2008.
- National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain). Opioids in palliative care : safe and effective prescribing of strong opioids for pain in palliative care of adults. Clinical guideline (National Institute for Clinical Excellence (Great Britain), Series Number 140. Cardiff:National Collaborating Centre for Cancer;2012.
- el Daly ES. Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat. Life Sci 1996;59:1881-90. https://doi.org/10.1016/S0024-3205(96)00535-8
- Aloisi AM, Aurilio C, Bachiocco V, Biasi G, Fiorenzani P, Pace MC, et al. Endocrine consequences of opioid therapy. Psychoneuroendocrinology 2009;34 Suppl 1:S162-8. https://doi.org/10.1016/j.psyneuen.2009.05.013
- Rhodin A, Stridsberg M, Gordh T. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain 2010;26:374-80. https://doi.org/10.1097/AJP.0b013e3181d1059d
- Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000; 85:2215-22. https://doi.org/10.1210/jcem.85.6.6615
- Oltmanns KM, Fehm HL, Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 2005;257: 478-80. https://doi.org/10.1111/j.1365-2796.2005.01483.x
- Policola C, Stokes V, Karavitaki N, Grossman A. Adrenal insufficiency in acute oral opiate therapy. Endocrinol Diabetes Metab Case Rep 2014;2014:130071.
- Mussig K, Knaus-Dittmann D, Schmidt H, Morike K, Haring HU. Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment. Clin Endocrinol (Oxf) 2007;66:604-5.
- Daniell HW. DHEAS deficiency during consumption of sustainedaction prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J Pain 2006;7:901-7. https://doi.org/10.1016/j.jpain.2006.04.011
- Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008;9:28-36.
- Daniell HW. Opioid contribution to decreased cortisol levels in critical care patients. Arch Surg 2008;143:1147-8. https://doi.org/10.1001/archsurg.143.12.1147
- Merza Z, Edwards N, Walters SJ, Newell-Price J, Ross RJ. Patients with chronic pain and abnormal pituitary function require investigation. Lancet 2003;361:2203-4. https://doi.org/10.1016/S0140-6736(03)13775-0
- Ihde JK, Turnbull AD, Bajorunas DR. Adrenal insufficiency in the cancer patient: implications for the surgeon. Br J Surg 1990; 77:1335-7. https://doi.org/10.1002/bjs.1800771206
- Schimke KE, Greminger P, Brändle M. Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration. Exp Clin Endocrinol Diabetes 2009;117:649-51. https://doi.org/10.1055/s-0029-1202851
- Rajagopal A1, Vassilopoulou-Sellin R, Palmer JL, Kaur G, Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 2004;100:851-8. https://doi.org/10.1002/cncr.20028
- Lee C, Ludwig S, Duerksen DR. Low-serum cortisol associated with opioid use: case report and review of the literature. Endocrinologist 2002;12:5-8. https://doi.org/10.1097/00019616-200201000-00002
- Colameco S, Coren JS. Opioid-induced endocrinopathy. J Am Osteopath Assoc 2009;109:20-5.
- Dehydroepiandrosterone sulfate (DHEA-S), serum [Internet]. Rochester, MN: Mayo Medical Laboratories; 2012. [cited 2014 Jul 20]. Available from: http://www.mayomedicallaboratories.com/testcatalog/ setup.php?unit_code=8493&format=pdf.
- Arlt W, Allolio B. Adrenal insufficiency. Lancet 2003;361:1881-93. https://doi.org/10.1016/S0140-6736(03)13492-7
피인용 문헌
- The Relationship between Opioids Use, Cortisol and DHEAS vol.18, pp.2, 2015, https://doi.org/10.14475/kjhpc.2015.18.2.105
- 한방치료를 통한 허로환자의 증상개선과 DHEAS 수치개선의 연관성에 관한 증례보고 2례 vol.37, pp.6, 2016, https://doi.org/10.22246/jikm.2016.37.6.1059